Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-15

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Androgenetic alopecia is the most common type of alopecia in both men and women. About 80 % of Caucasian men and 40-50 % of Caucasian women are affected by androgenetic alopecia. The psychological impact of hair loss due to Androgenetic alopecia can be profound.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia

NCT06558565

Androgenetic Alopecia

NOT_YET_RECRUITING NA

Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP

NCT05251831

Alopecia Areata

COMPLETED EARLY_PHASE1

Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation

NCT07287579

Androgenic Alopecia

NOT_YET_RECRUITING NA

Successful Treatment of Female Pattern Hair Loss With Injection of Nanofat With and Without Platelet-Rich Plasma

NCT07096323

Female Pattern Hair Loss

COMPLETED NA

Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia

NCT02074943

Androgenetic Alopecia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently, two medications are Food and Drug Administration approved in the treatment of Androgenetic alopecia which are minoxidil, and finasteride. Both medications must be taken indefinitely for benefits to persist. Hair transplantation is the only current successful permanent option. Nowadays, the majority of surgeons use 2 techniques, the classic strip technique, and the follicular unit extraction technique. Advantages of follicular unit extraction over the strip technique are the lesser incidence of donor zone post-procedural discomfort and the barely visible scarring.

Platelet rich plasma is an autologous concentration of platelets in small volume of plasma and is an exciting therapeutic option for hair growth. Combining platelet rich plasma with follicular unit extraction surgery for the treatment of Androgenetic alopecia demonstrated that PRP is able to minimize the postsurgical follicle loss and potentiate the performance of grafted hairs.

Adipose derived stem cells are an effective mesenchymal stem cell population with enormous potential in different fields of regenerative medicine.

Adipose stem cells are needed to induce the proliferation of bulge stem cells of hair follicle. Furthermore, they can help in wound healing and vascular neogenesis.

Zanzottera et al. 2014 investigated the effect of adipose derived stem cells on wound healing and engraftment of the transplanted hair applied during hair restoration surgery for three patients with androgenetic alopecia. Despite their promising results, further clinical trials including larger number of patients are still needed to confirm their preliminary findings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Androgenetic Alopecia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adipose derived stem cells suspention

suspension rich in adipose derived stem cells plus platelet rich plasma will be injected at the recipient site during follicular unit extraction for treatment of androgenetic alopecia

Group Type EXPERIMENTAL

Adipose derived stem cells suspention

Intervention Type BIOLOGICAL

application of adipose derived stem cells to the engrafted hair in hair transplantation surgery

Platelet rich plasma

platelet rich plasma will be injected at the recipient site during follicular unit extraction for treatment of androgenetic alopecia

Group Type ACTIVE_COMPARATOR

Platelet rich plasma

Intervention Type BIOLOGICAL

application of autologous platelet rich plasma to the engrafted hair in hair transplantation surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adipose derived stem cells suspention

application of adipose derived stem cells to the engrafted hair in hair transplantation surgery

Intervention Type BIOLOGICAL

Platelet rich plasma

application of autologous platelet rich plasma to the engrafted hair in hair transplantation surgery

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male patients with androgenetic alopecia between 18 years and 60 years

Exclusion Criteria

1. Patients with Non-androgenetic causes of hair loss.
2. Female patients with androgenetic alopecia.
3. Patients who received anti-hair loss treatment within the past six months.
4. Patients with history of bleeding disorders or on anticoagulant therapy.
5. Patients with history of chronic liver disease, cancer or connective tissue disorders.
6. Patients with current scalp infection.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No